600196 复星医药
2023/122022/122021/122020/122019/12

盈利能力分析
净资产收益率 ROE (%)5.2878.90612.41310.63511.097
总资产报酬率 ROA (%)2.1633.7225.3434.5844.529
投入资产回报率 ROIC (%)2.7584.8446.9465.8035.598

边际利润分析
销售毛利率 (%)47.83747.28448.14454.68559.617
营业利润率 (%)7.98910.59516.15615.57815.720
息税前利润/营业总收入 (%)10.26311.88116.67917.82518.860
净利润/营业总收入 (%)6.9938.98112.75613.00013.096

收益指标分析
经营活动净收益/利润总额(%)3.53756.95431.74036.60431.763
价值变动净收益/利润总额(%)94.18141.08782.35061.19670.979
营业外收支净额/利润总额(%)-1.315-1.799-4.301-0.9260.711

偿债能力分析
流动比率 (X)1.0011.0591.0381.0091.170
速动比率 (X)0.7780.8530.8510.8010.944
资产负债率 (%)50.10449.50848.15045.05148.497
带息债务/全部投入资本 (%)38.27337.44735.13736.98936.008
股东权益/带息债务 (%)133.295142.559158.135152.417146.085
股东权益/负债合计 (%)80.35584.03187.24398.12786.381
利息保障倍数 (X)4.3178.06614.0227.4596.229

营运能力分析
应收账款周转天数 (天)66.22655.77148.88353.05150.321
存货周转天数 (天)120.19495.98394.631119.314112.707